What are the latest funding news in the digital health market? (April 2026)

Last updated: 23 April 2026

Download our beautiful pitch about the digital health market

market research pitch 2026 statistics digital health market

In our digital health market deck, you will find everything you need to understand the market

Digital health funding in April 2026 keeps pointing in one clear direction, which is infrastructure that quietly reshapes how care is delivered, paid for, and documented.

From AI governance platforms for hospitals to prior authorization engines for specialty drugs, investors are backing workflow-native products that sit right next to clinicians and payers.

The twelve most recent deals we tracked show a market maturing fast, with checks flowing toward companies that already have real customers and measurable operational impact.

And if you want to better understand this new industry, you can download our pitch covering the digital health market.

Insights

  • Of the twelve qualifying rounds we tracked, eight went to companies building AI-powered clinical or administrative workflow software, signaling that digital health investors are now clearly prioritizing provider-facing infrastructure over consumer health apps.
  • More than $698 million was deployed across these twelve rounds in roughly four weeks, with a single deal (Verily at $300 million) accounting for over 40 percent of that total, showing how capital is concentrating into scaled platforms.
  • Series A was the most common round type in this batch, with six of the twelve deals landing at that stage, suggesting the digital health market is producing a healthy pipeline of validated startups moving past seed risk.
  • Anthropic appeared as an investor in two separate rounds (Yuzu Health and Qualified Health), which is a quietly important signal that frontier AI labs are now taking direct equity positions in healthcare AI infrastructure.
  • Nine of twelve companies sell to health systems, payers, or employers rather than directly to patients, reinforcing that B2B2C and pure B2B distribution have become the dominant go-to-market pattern in digital health.
  • Three deals in this batch focused on medication and care access workflows (Latent Health, Conduit Health, Lantern), which together pulled in $127 million, pointing to prior authorization and specialty care navigation as one of the hottest digital health subcategories right now.
  • Behavioral health saw only one qualifying round (Jimini Health at $17 million), suggesting that after years of heavy funding, investor enthusiasm for mental health tech has cooled toward more clinically supervised, enterprise-grade models.
  • Every single company on this list is primarily US-focused, which continues a multi-year pattern of American healthcare complexity driving the vast majority of digital health venture activity globally.
  • Only two of the twelve companies disclosed even a rough valuation band (Qualified Health and Latent Health), reflecting a broader trend where digital health founders are increasingly comfortable raising meaningful rounds without publicly anchoring expectations.
  • General Catalyst and Transformation Capital each appeared in multiple rounds this month, confirming their position as two of the most active repeat backers shaping the current digital health infrastructure wave.
Google Trends chart showing rising interest in longevity apps

As this chart shows, and as featured in our digital health market deck, search interest in longevity apps and related topics has been increasing

Summary table of the latest funding deals in the digital health market as of April 2026

We define the digital health market as products and services that use digital technology to deliver, support, or improve health care and health outcomes.

We include telehealth and virtual care, remote monitoring and connected devices, health IT and clinical workflow software, and patient-facing mobile apps when they are health-focused.

We exclude generic enterprise IT, purely consumer fitness and wellness products with no health use case, and biotech or lab R&D tools unless they directly power care delivery or clinical decision-making.

You can also read our detailed analysis to understand how funding activity in the digital health market has evolved over the last few years.

We also have a quarter-by-quarter analysis of funding activity in the market here.

Finally, you can check our complete list of fundraising deals for the digital health market (we update this list every quarter) as well as our ranking of the most funded startups.

Name When Amount in $ Round Type Category
Translucent March 11, 2026 $27M Series A Health IT & Provider Operations
Conduit Health March 17, 2026 $17M Series A Home Care Access & DME Workflow
Latent Health March 18, 2026 $80M Series A Medication Access & Workflow Automation
Verily March 19, 2026 $300M Investment round Precision Health & Clinical AI Infrastructure
Lantern March 19, 2026 $30M Strategic investment Care Navigation & Specialty Care
Health Universe March 19, 2026 $6M Seed Enterprise Healthcare AI Platform
Doctronic March 23, 2026 $40M Series B Telehealth & Virtual Care
Qualified Health March 25, 2026 $125M Series B Health System AI Infrastructure
Avo March 31, 2026 $10M Series A Clinical Decision Support & Workflow AI
Jimini Health March 31, 2026 $17M Seed Behavioral Health & Patient-Facing AI
Insight Health April 3, 2026 $11M Series A Clinical Workflow Software
Yuzu Health April 6, 2026 $35M Series A Payer & Health Plan Infrastructure

All the latest funding deals during in the digital health market as of April 2026

Yuzu Health secured a $35 million Series A in early April 2026 to scale its health plan infrastructure platform

When was it?

The deal was announced on April 6, 2026.

Who are they?

Yuzu Health builds the back-end software that lets brokers and plan designers launch and run modern health plans, covering claims, payments, and member administration.

Geographical focus?

Yuzu Health is focused on the United States market.

Why do we include them in the digital health market?

Yuzu Health is a healthcare-specific digital platform used to operate health coverage and benefits delivery, which places it squarely in payer and health plan infrastructure.

What is the company stage?

Yuzu Health is at the PMF and growth stage, with a live platform, named customers, and active national scaling.

How much did they raise?

Yuzu Health raised $35 million in this round.

What round is it?

This was a Series A round.

Why did they raise?

Yuzu Health raised the capital to automate more of the manual health plan operations layer and scale its platform nationally.

Insight Health closed an $11 million Series A in early April 2026 to expand its clinical AI agent platform

When was it?

The deal was announced on April 3, 2026.

Who are they?

Insight Health makes voice, chat, and ambient-scribe AI agents for clinics, handling intake, referrals, documentation, and other routine clinical admin work.

Geographical focus?

Insight Health is focused on US healthcare providers.

Why do we include them in the digital health market?

Insight Health belongs in digital health because the product is purpose-built for clinical operations and patient interactions inside care settings, fitting clinical workflow software.

What is the company stage?

Insight Health is at PMF moving into growth, with millions of autonomous clinical conversations already completed and named provider customers.

How much did they raise?

Insight Health raised $11 million in this round.

What round is it?

This was a Series A round.

Why did they raise?

Insight Health raised to accelerate product development and expand partnerships with healthcare organizations trying to cut admin burden and clinician burnout.

Chart comparing business model options for digital health SaaS platforms

This chart, featured in our digital health market deck, compares the main business model options for digital health SaaS platforms

Jimini Health raised a $17 million seed round at the end of March 2026 to scale clinician-supervised behavioral health AI

When was it?

The deal was announced on March 31, 2026.

Who are they?

Jimini Health is building clinician-supervised AI for behavioral health systems, with patient-facing mental health support that stays under provider oversight.

Geographical focus?

Jimini Health is focused on the US behavioral health provider market.

Why do we include them in the digital health market?

Jimini Health fits because it is a health-focused digital care product embedded inside provider workflows, in the behavioral health and patient-facing care category.

What is the company stage?

Jimini Health is at MVP to early PMF, with a live product moving into partnerships with major provider organizations.

How much did they raise?

Jimini Health raised $17 million in this round.

What round is it?

This was a seed round.

Why did they raise?

Jimini Health raised because behavioral health providers need a safer way to handle the surge of patient AI use between visits without losing clinician oversight or compliance.

Avo locked in a $10 million Series A at the end of March 2026 to deepen its clinical AI platform inside health systems

When was it?

The deal was announced on March 31, 2026.

Who are they?

Avo turns EHRs into AI-assisted clinical workflow systems, helping clinicians with charting, consults, clinical pathways, and decision support.

Geographical focus?

Avo is focused on US hospitals and health systems.

Why do we include them in the digital health market?

Avo belongs in digital health because the product is directly used in clinical decision-making and workflow execution inside care delivery, fitting clinical decision support.

What is the company stage?

Avo is at PMF stage, integrated into major EHR environments and already serving enterprise healthcare organizations.

How much did they raise?

Avo raised $10 million in this round.

What round is it?

This was a Series A round.

Why did they raise?

Avo raised to deepen the platform's role as a trusted, knowledge-powered AI layer inside clinical workflows.

Chart showing how Hinge Health captured share in the digital health market

This chart, featured in our digital health market deck, shows how Hinge Health captured share in digital health

Qualified Health banked a $125 million Series B in late March 2026 to scale enterprise AI governance across health systems

When was it?

The deal was announced on March 25, 2026.

Who are they?

Qualified Health sells an enterprise AI platform that helps health systems evaluate, govern, and deploy AI across clinical and administrative workflows.

Geographical focus?

Qualified Health is focused on the US hospital and health system market.

Why do we include them in the digital health market?

Qualified Health fits because the product is healthcare-specific infrastructure for safe AI deployment in live care environments, in the health system AI infrastructure category.

What is the company stage?

Qualified Health is at growth stage, already working with major health systems and supporting hundreds of thousands of users.

How much did they raise?

Qualified Health raised $125 million in this round at a reported valuation between $500 million and $1 billion.

What round is it?

This was a Series B round.

Why did they raise?

Qualified Health raised to go deeper with existing health system customers and invest in product development and engineering as enterprise AI adoption accelerates.

Doctronic garnered a $40 million Series B in late March 2026 to expand its AI-plus-physician virtual care platform

When was it?

The deal was announced on March 23, 2026.

Who are they?

Doctronic offers a HIPAA-compliant AI doctor alongside access to licensed physicians via video, supporting triage, consultation, and prescribing.

Geographical focus?

Doctronic is focused on the US market.

Why do we include them in the digital health market?

Doctronic belongs because the product directly supports patient consultation, triage, and care access, which sits firmly in telehealth and virtual care.

What is the company stage?

Doctronic is at PMF stage, with substantial consumer usage, a licensed clinical practice, and growing institutional partnerships.

How much did they raise?

Doctronic raised $40 million in this round.

What round is it?

This was a Series B round.

Why did they raise?

Doctronic raised to expand into pediatrics and push further into academic medical centers, payers, digital health platforms, and hospital systems.

Table scoring and prioritizing the main pain points faced by companies in the digital health market

In our digital health market deck, we identify pain points entrepreneurs should prioritize

Verily secured a $300 million investment round in mid-March 2026 to accelerate its precision health AI strategy

When was it?

The deal was announced on March 19, 2026.

Who are they?

Verily is building an AI-native precision health platform that transforms complex health data for research and care delivery.

Geographical focus?

Verily is primarily US-focused in its operational footprint.

Why do we include them in the digital health market?

Verily belongs because its platform is explicitly built to improve care and health outcomes through healthcare-specific data and AI, in precision health and clinical AI infrastructure.

What is the company stage?

Verily is at scale stage, long-established and heavily capitalized, now separating further from Alphabet operationally.

How much did they raise?

Verily raised $300 million in this round.

What round is it?

This was described as an investment round rather than a traditional named series.

Why did they raise?

Verily raised to accelerate the next phase of its precision health AI strategy and support the transition to a more independent capital structure.

Lantern pulled in a $30 million strategic investment in mid-March 2026 to scale its specialty care navigation platform

When was it?

The deal was announced on March 19, 2026.

Who are they?

Lantern runs a specialty care platform that steers members to high-quality surgery, infusion, and cancer care.

Geographical focus?

Lantern is focused on the US employer and health plan market.

Why do we include them in the digital health market?

Lantern belongs because the platform directly influences how patients access care and how specialty care pathways are managed, in care navigation and specialty care.

What is the company stage?

Lantern is at growth stage, serving 12 million people and adding large employer clients.

How much did they raise?

Lantern raised $30 million in this round.

What round is it?

This was a strategic investment rather than a named series.

Why did they raise?

Lantern raised to scale across public and private employers and health plans, with a focus on lowering specialty care costs and improving outcomes.

Market map chart showing top companies and startups in the digital health market

This market map, featured in our digital health market deck, highlights top companies and startups in the digital health market

Health Universe raised a $6 million seed round in mid-March 2026 to scale AI agents inside healthcare organizations

When was it?

The deal was announced on March 19, 2026.

Who are they?

Health Universe provides a secure enterprise platform for deploying AI agents that automate complex healthcare workflows.

Geographical focus?

Health Universe is primarily focused on US health systems and research institutions.

Why do we include them in the digital health market?

Health Universe fits because the product is a healthcare-specific, HIPAA-compliant platform used inside regulated medical environments, in enterprise healthcare AI infrastructure.

What is the company stage?

Health Universe is at early PMF, with real production workflows and a large volume of clinical documents processed, but still seed stage.

How much did they raise?

Health Universe raised $6 million in this round.

What round is it?

This was a seed round.

Why did they raise?

Health Universe raised to scale trusted AI agents across more healthcare institutions and automate workflows that otherwise take months of manual work.

Latent Health emerged with an $80 million Series A in mid-March 2026 to speed medication access for patients

When was it?

The deal was announced on March 18, 2026.

Who are they?

Latent Health uses AI to speed medication access, especially prior authorization and specialty drug workflows inside health systems and pharmacies.

Geographical focus?

Latent Health is focused on the US health system and pharmacy market.

Why do we include them in the digital health market?

Latent Health belongs because the product directly powers care delivery logistics and treatment access, in medication access and provider workflow automation.

What is the company stage?

Latent Health is at growth stage, already working with a large share of major US health systems and serving millions of patients annually.

How much did they raise?

Latent Health raised $80 million in this round, with Forbes describing the company as a $600 million startup.

What round is it?

This was a Series A round.

Why did they raise?

Latent Health raised to close the gap between diagnosis and treatment by accelerating approvals for advanced therapies and expanding the platform across health systems.

Chart showing the projected CAGR of the digital health market

This chart, featured in our digital health market deck, shows annual funding in digital health startups

Conduit Health raised a $17 million Series A in mid-March 2026 to rebuild the path to insurance-covered medical supplies

When was it?

The deal was announced on March 17, 2026.

Who are they?

Conduit Health simplifies how Medicare and Medicaid patients get insurance-covered home medical equipment by combining telehealth, insurance authorization, and fulfillment.

Geographical focus?

Conduit Health has a visible New York State and broader US Medicaid and Medicare focus.

Why do we include them in the digital health market?

Conduit Health belongs because the platform directly supports covered care delivery in the home and automates payer workflows tied to patient access, in remote care enablement and DME workflow.

What is the company stage?

Conduit Health is at early PMF, launched in late 2024 and already working with payers and referral partners.

How much did they raise?

Conduit Health raised $17 million in this round.

What round is it?

This was a Series A round.

Why did they raise?

Conduit Health raised to expand a vertically integrated model that cuts through delays and denials in getting patients medically necessary home equipment.

Translucent announced a $27 million Series A in mid-March 2026 to tackle the financial crisis facing health systems

When was it?

The deal was announced on March 11, 2026.

Who are they?

Translucent makes an AI platform for healthcare finance teams that gives health systems real-time visibility into operational, clinical, and financial risk.

Geographical focus?

Translucent is focused on the US health system market.

Why do we include them in the digital health market?

Translucent belongs because it is purpose-built for healthcare providers and directly supports the financial operating layer that keeps care organizations functioning, in health IT and provider operations.

What is the company stage?

Translucent is at PMF stage, with named health systems already using the platform, though still an early institutional software company.

How much did they raise?

Translucent raised $27 million in this round.

What round is it?

This was a Series A round.

Why did they raise?

Translucent raised to accelerate product development and expand the platform across health systems facing margin pressure and financial complexity.

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page. You can also follow us on Instagram or on Facebook.

How we created this content 🔎📝

At New Market Pitch, we kept seeing the same problem: when you look at a new market, the data is either missing, paywalled, or buried in 300-page reports that feel like they were written in the 80s. On the other side, LLMs and random blog posts give you confident answers with no sources, and sometimes they just make things up. That’s not good enough when you’re about to invest real money or launch a company.

So we decided to fix the experience. For each market we cover, we build a structured database and update it on a regular basis. We track funding rounds, fund memos, M&A moves, partnerships, new products, policy changes, and the real activity of startups and incumbents. Then we turn all of that into a clear “market pitch” that shows where the opportunities are and how people actually win in that space.

Every key data point is checked, sourced, and put back into context by our team. That’s how we can give you both speed and reliability: fast coverage of new markets, without the usual guesswork.

Back to blog